Search over 3,000 reports

    Risperdal Consta- Drug Insight, 2017

    Risperdal Consta- Drug Insight, 2017
    Date: Jan, 2018
    Type: Pharmaceutical Industry Report
    Pages: 35
    Geography: Global
    Delivery Timeline: 48 hours
    SKU: DIDI0244
    "Risperdal Consta - Drug Insight, 2018" report by DelveInsight provides comprehensive information of the drug, Risperdal Consta. It includes Risperdal Consta`s overview, mechanism, clinical trials, regulatory milestones, deals & partnerships. It further provides Risperdal Consta`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted sales of Risperdal Consta till 2020. The report also throws light on Risperdal Consta`s market competition and emerging therapies in the same space as Risperdal Consta. A SWOT analysis of Risperdal Consta is also featured.
    * Depending on information availability

    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Scope of the report
    • A comprehensive product overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
    • Patent information around Risperdal Consta in United States (US) and Europe (EU) has been highlighted
    • API manufacturers for Risperdal Consta in United States, Europe, China and India
    • The report contains historical and forecasted sales for Risperdal Consta till 2020
    • Comprehensive coverage of the emerging therapies (Phase III) in the space where Risperdal Consta operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
    • The report also features the SWOT analysis of Risperdal Consta

    Reasons to Buy
    • Establish a comprehensive understanding of the drug, Risperdal Consta
    • Access to Risperdal Consta`s API manufacturers details to devise API procurement strategy for generic development
    • Plan developmental timelines around Risperdal Consta`s patents for the major markets- US and EU
    • Understand Risperdal Consta`s current and future growth through its historical and forecasted sales
    • Identify and understand the current in-market competitors for Risperdal Consta
    • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
    • Identify and plan ahead for prospective emerging players and their products operating in the same space as Risperdal Consta
    • Identify opportunities in the same area as Risperdal Consta with DelveInsight`s SWOT analysis
    1. Report Introduction
    2. Risperdal Consta - Overview
    • Product Description
    • Route of Synthesis
    • Mechanism of Action
    • Pharmacology
    • Pharmacodynamics
    • Pharmacokinetics
    • Adverse Reactions
    • Clinical Trials
    • Regulatory Milestones
    • Product Development Activities
    3. Global API Manufacturers
    • United States
    • Europe
    • China
    • India
    4. Product Details
    • United States
    • Europe
    5. Risperdal Consta Global Sales Assessment
    • Historical Global Sales
    • Forecasted Global Sales
    6. Patent Details
    7. Market Competition
    8. Emerging Therapies
    8.1. Drug name: Company name
    • Product Description
    • Research & Development
    • Product Development Activities
    Other product profiles in the detailed report…..
    9. SWOT Analysis
    Consulting Services
    About DelveInsight
    Contact Us
    Note: Certain sections of the table of contents would vary according to the availability of information
    Table 1: Risperdal Consta, Description
    Table 2: API Manufacturers Region wise
    Table 3: API Manufacturers for United States
    Table 4: API Manufacturers for Europe
    Table 5: API Manufacturers for China
    Table 6: API Manufacturers for India
    Table 7: Risperdal Consta Product Details, United States
    Table 8: Risperdal Consta Product Details, Europe
    Table 9: Risperdal Consta, Historical Global Sales till 2017 (in million USD)
    Table 10: Risperdal Consta, Forecasted Global Sales from 2018-2020 (in million USD)
    Table 11: Patent Details: Risperdal Consta
    Table 12: Risperdal Consta Major Competitors
    Table 13: Emerging Therapies
    Figure 1: Risperdal Consta
    Figure 2: Risperdal Consta, Historical Global Sales till 2017 (in million USD)
    Figure 3: Risperdal Consta, Forecasted Global Sales from 2018-2020 (in million USD)
    Figure 4: Patent Details: Risperdal Consta
    Figure 5: API Manufacturers Region wise
    Risperdal Consta

    Risperdal Consta Marketed Drugs Overview

    Risperdal Consta Market Assessment

    Risperdal Consta API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers

    Risperdal Consta US DMF

    Risperdal Consta US Drug Master Files

    Risperdal Consta Active Substance Master File/ EUDMF

    Risperdal Consta Generic players

    Risperdal Consta Patent Expiration

    Risperdal Consta Patent Exclusivity

    Risperdal Consta API Manufacturers

    Risperdal Consta Global Forecasted Sales Figure

    Risperdal Consta API Route of Synthesis

    Risperdal Consta Market sales

    Risperdal Consta SWOT Analysis

    Risperdal Consta Pipeline

    • Single User License
      (20% Off)
    • Site License
      (30% Off)
    • Global License
      (40% Off)

    Contact Us

    +91-11-45689769, +91 9650213330


    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap